Quick Answer
Harvard Apparatus Regenerative Technology, Inc. reported Cash and Equivalents of $1.35 million for fiscal year 2025.
Harvard Apparatus Regenerative Technology, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $1.35M | -45.6% |
| 2024 | $2.49M | +475.5% |
| 2023 | $432.0K | -65.2% |
| 2022 | $1.24M | -57.8% |
| 2016 | $2.94M | -60.6% |
| 2015 | $7.46M | +41.4% |
| 2014 | $5.27M | -62.4% |
| 2013 | $14.01M | — |
| 2012 | $0.00 | — |
| 2011 | $0.00 | — |
| 2009 | $0.00 | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.32M | -63.3% | +67.8% |
| June 30, 2025 | $786.0K | +465.5% | -54.5% |
| March 31, 2025 | $1.73M | +535.3% | -30.5% |
| December 31, 2024 | $2.49M | +475.5% | -30.8% |
| September 30, 2024 | $3.59M | +1235.7% | +2484.9% |
| June 30, 2024 | $139.0K | -93.5% | -48.9% |
| March 31, 2024 | $272.0K | — | -37.0% |
| December 31, 2023 | $432.0K | -65.2% | +60.6% |
- Harvard Apparatus Regenerative Technology, Inc. showed a decrease of -45.6% in Cash and Equivalents compared to the prior fiscal year.
- The most recent figure is from Harvard Apparatus Regenerative Technology, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: